See more : China Demeter Financial Investments Limited (8120.HK) Income Statement Analysis – Financial Results
Complete financial analysis of WDB coco Co., Ltd. (7079.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of WDB coco Co., Ltd., a leading company in the Healthcare industry within the Healthcare sector.
- Microlink Solutions Berhad (0126.KL) Income Statement Analysis – Financial Results
- Helo Corp. (HLOC) Income Statement Analysis – Financial Results
- BH Macro Limited (BHMG.L) Income Statement Analysis – Financial Results
- Wuhan Youji Holdings Ltd (2881.HK) Income Statement Analysis – Financial Results
- Cypress Environmental Partners, L.P. (CELP) Income Statement Analysis – Financial Results
WDB coco Co., Ltd. (7079.T)
About WDB coco Co., Ltd.
WDB coco Co., Ltd. provides contract services to pharmaceutical companies in Japan. The company supports the development of pharmaceuticals and medical devices with a focus on safety information management; safety information management support; clinical research support; and post-marketing safety information management operations services. It also provides support for the preparation of various translation, and QC; clinical research support; and manpower dispatch services. In addition, the company offers post-marketing surveillance (PMS) services, such as contract conclusion with medical facilities, survey explanations, receipt of survey forms, monitoring services, including conducting re-surveys, case registration center, data management, and statistical analysis. WDB coco Co., Ltd. was incorporated in 1984 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 4.60B | 4.07B | 3.62B | 2.57B | 2.29B |
| Cost of Revenue | 2.66B | 2.48B | 2.18B | 1.67B | 1.41B |
| Gross Profit | 1.94B | 1.59B | 1.44B | 903.33M | 871.00M |
| Gross Profit Ratio | 42.23% | 39.04% | 39.81% | 35.14% | 38.12% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 57.00M | 58.00M | 54.00M | 44.00M | 0.00 |
| Selling & Marketing | 603.00M | 440.00M | 418.00M | 332.00M | 0.00 |
| SG&A | 660.10M | 498.00M | 472.00M | 376.00M | 396.00M |
| Other Expenses | 8.00M | 2.22M | 12.00K | 2.59M | 0.00 |
| Operating Expenses | 667.76M | 503.41M | 475.86M | 378.63M | 426.00M |
| Cost & Expenses | 3.32B | 2.98B | 2.65B | 2.05B | 1.84B |
| Interest Income | 31.00K | 18.00K | 13.00K | 10.00K | 5.00K |
| Interest Expense | 140.00K | 157.00K | 137.00K | 64.00K | 27.00K |
| Depreciation & Amortization | 32.98M | 31.94M | 18.35M | 11.35M | 9.00M |
| EBITDA | 1.31B | 1.12B | 978.74M | 538.66M | 482.00M |
| EBITDA Ratio | 28.42% | 27.51% | 27.15% | 20.95% | 21.09% |
| Operating Income | 1.27B | 1.09B | 963.36M | 524.70M | 473.00M |
| Operating Income Ratio | 27.70% | 26.67% | 26.65% | 20.41% | 20.70% |
| Total Other Income/Expenses | 62.00K | 1.91M | -3.10M | 2.54M | -27.27M |
| Income Before Tax | 1.27B | 1.09B | 960.26M | 527.24M | 445.00M |
| Income Before Tax Ratio | 27.70% | 26.72% | 26.56% | 20.51% | 19.47% |
| Income Tax Expense | 415.06M | 344.11M | 312.56M | 154.06M | 139.00M |
| Net Income | 857.83M | 743.63M | 647.70M | 373.18M | 306.00M |
| Net Income Ratio | 18.67% | 18.27% | 17.92% | 14.52% | 13.39% |
| EPS | 356.81 | 311.24 | 273.94 | 163.11 | 147.32 |
| EPS Diluted | 356.47 | 309.31 | 269.64 | 156.04 | 140.67 |
| Weighted Avg Shares Out | 2.40M | 2.39M | 2.36M | 2.29M | 2.08M |
| Weighted Avg Shares Out (Dil) | 2.41M | 2.40M | 2.40M | 2.39M | 2.18M |
Source: https://incomestatements.info
Category: Stock Reports